A Novel Biomarker for Early Diagnosis of Alzheimer’s Disease
Astrocytic α7-subunit of the nicotinic acetylcholine receptors (α7nAChRs) have been implicated as a novel biomarker for the diagnosis of early Alzheimer's disease.
Combining brain imaging data with machine learning, researchers make new discoveries about how the brain controls the hand. The findings could lead to the development of more advanced neuroprosthetics. from Neuroscience News https://ift.tt/3tv7BbC
Astrocytic α7-subunit of the nicotinic acetylcholine receptors (α7nAChRs) have been implicated as a novel biomarker for the diagnosis of early Alzheimer's disease.
Comments
Post a Comment